Renal Cell Carcinoma with Venous Tumor Thrombus: Surgical Techniques and Survival Outcomes

Abstract

Introduction: Renal cell carcinoma (RCC) extends into the renal vein/inferior vena cava (IVC) in 4–10% of cases. Radical nephrectomy with thrombectomy is standard, but morbidity is high. This review compares surgical approaches and reports contemporary survival.

Methods: A systematic review of PubMed, Embase, and Scopus (2010–2024) for series of ≥20 patients undergoing RCC thrombectomy. Thrombus level classified by Neves-Zincke. Outcomes: perioperative mortality, major complications (Clavien ≥3), and 5-year cancer-specific survival (CSS).

Results: Forty-eight studies (n=6,109) were analyzed. Level I (renal vein) 5-year CSS 68%, Level II (infrahepatic IVC) 58%, Level III (retrohepatic) 49%, Level IV (supradiaphragmatic) 41%. Cardiopulmonary bypass was required for 89% of Level IV. Overall perioperative mortality was 5.2% (range 2–12%). Major complication rate 22%. Use of tumor thrombus fragmentation vs. en bloc resection did not affect survival.

Discussion: Survival strongly correlates with thrombus level and presence of metastases, not just surgical radicality. Most studies are retrospective with selection bias. Standardized reporting of thrombus consistency (friable vs. organized) is lacking.

Conclusions: Surgical thrombectomy for RCC with IVC thrombus provides acceptable long-term survival for Level I–II. Level IV carries significant mortality and should be centralized to high-volume centers. Neoadjuvant targeted therapy may downstage thrombus but lacks evidence.